("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today that the European Patent Office ...

This launch marks a significant milestone in the Company's ongoing regional expansion strategy. Mr. Mei Kanayama, Principal ...

GM started selling EVs in Europe last year. It now has four EV experience centers open for Europeans to see Cadillac EVs in ...

The Trump regime will hit European economic growth and reduce company earnings, though the continent’s defense sector may ...

The victory of Donald Trump in the US Presidential elections delivered a shock wake-up for the stocks of European companies ...

MRUS), a clinical-stage immune-oncology biotechnology company. Their pipeline consists of several programs targeting solid ...

Nazara Technologies rose 1.05% after the company announced its integration with the Open Network for Digital Commerce (ONDC) to launch "gCommerce." Most of the European stocks declined as investors ...

Teva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by ...

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a ...

European stocks tumbled on Tuesday and several markets recorded their biggest single-session decline in several weeks, as concerns ...

The Western Balkan country hopes to build not only a road but also closer ties to the EU in hopes of joining the bloc in the ...

European clean energy stocks saw a significant drop after Donald Trump’s victory in the US presidential election, Reuters ...